BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Colorcon Enters Exclusive Partnership with ASHA Cellulose to Expand Ethyl Cellulose Offerings Across Asia, EMEA

Colorcon, a global leader of film coating systems, specialty excipients, controlled release formulations and controlled atmosphere packaging for the health...

May 09, 2025 | News

Altaris Unites WuXi and Minaris Assets to Launch Minaris Advanced Therapies as Global Cell Therapy CDMO Powerhouse

Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and U.K. operations of WuXi...

May 08, 2025 | News

Taiwan’s Formosa Pharmaceuticals Partners with Apotex to Commercialize APP13007 in Mexico for Post-Ocular Surgery Treatment

Taiwan-based Formosa Pharmaceuticals announced that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), ...

May 07, 2025 | News

Waters Integrates MALS into Empower™ Software to Accelerate Biologics QC and Slash Validation Time

Saves up to six months on compliant software validation in biopharmaceutical quality control. Reduces analysis time for biotherapeutic peptides and prot...

May 07, 2025 | News

Beijing Tide Begins Phase II Trial of First-in-Class Non-Opioid CPSP Drug TRD205

Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited (1177.HK), has achieved a milestone in developing its first-in-class ...

May 06, 2025 | News

Turn Therapeutics Achieves Breakthrough in Room-Temperature Vaccine Stability with 100% Live Virus Recovery

Turn Therapeutics, a clinical-stage pharmaceutical and medical device company, announced that it has achieved a critical milestone in its effort to r...

May 05, 2025 | News

Asimov and Cytiva Unite to Fast-Track Complex Biologics Production

Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell line development and c...

April 30, 2025 | News

Henlius Licenses Ipilimumab Biosimilar HLX13 to Sandoz in $301M Global Deal

Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations Henlius to receive $...

April 30, 2025 | News

RoosterBio and Thermo Fisher Partner to Accelerate Cell and Exosome Therapy Development

RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services,&n...

April 30, 2025 | News

Eppendorf Enhances Automated Liquid Handling Efficiency With New epMotion® 4-Channel Tools

Eppendorf is expanding its product range in the field of automated liquid handling with the introduction of three new epMotion® 4-channel dispensing to...

April 29, 2025 | News

Thermo Fisher Scientific Accelerates IND Timelines With Enhanced Platform and High-Yield CHO K-1 Cell Line

Enhanced platform technology and the addition of a robust, high-quality CHO K-1 cell line decreases lead time to Investigational New Drug (IND) Thermo Fis...

April 29, 2025 | News

Merck to Acquire SpringWorks Therapeutics for $3.9 Billion, Strengthening Rare Tumor Leadership

Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $3.9 bill...

April 28, 2025 | News

SimonMed Partners with Lunit to Advance AI-Powered Breast Cancer Detection Across the U.S.

SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce thei...

April 24, 2025 | News

Beckman Coulter Launches OptiMATE Gradient Maker to Speed Up Ultracentrifugation Workflows

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of the OptiMATE Gradient...

April 24, 2025 | News

Stay Connected